MedTrace Logo

Investigate the Effect of Ezetimibe, Simvastatin, and Omega 3- Fatty Acids on Dyslipidemia Patients: a Pharmacokinetics Based Study

NCT05080140 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2021-10-15

No results posted yet for this study

Summary

This randomized controlled pharmacokinetic based study will be carried out on patients with both sexes and various ages, plasma triglycerides levels, clinical health disorders and using different agents for treatment of their hyperlipidemia in order to access the optimal drug therapy with best cost effectiveness in the elderly cases under investigation.

Conditions

  • Hyperlipidemia; Mixed

Interventions

DRUG

Ezetimibe 10mg

Effect of ezetimibe on hyperlipidemia on patients with diabetes mellites

Sponsors & Collaborators

  • Misr University for Science and Technology

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2021-07-01
Completion
2022-03-20
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05080140 on ClinicalTrials.gov